Ebola Outbreak in Congo-Uganda Involves Untreatable Bundibugyo Strain
The ongoing Ebola outbreak has surpassed 500 cases with no vaccine or treatment available for the Bundibugyo virus responsible for the infections
Category
Health & Public Health
Health & Public Health covers major developments in healthcare, medicine, medical research, public health, food safety, health policy, insurance, drug safety, and safety issues affecting readers in the United States and around the world. This section focuses on clear, factual reporting from credible sources, including government health agencies, medical research institutions, public health organizations, and trusted news outlets. Coverage may include FDA updates, NIH research, disease prevention, healthcare costs, medication safety, public health alerts, hospital systems, and policy decisions that affect patients and communities.
ACA Enrollment Drops Fuel Premium Increases for 2027
Declining Affordable Care Act enrollment due to rising premiums and reduced subsidies is prompting insurers to raise rates again next year
At Least Six Americans Exposed to Ebola in Congo Outbreak
Multiple Americans have been exposed to the Ebola virus in Congo amid a worsening outbreak declared a global health emergency
Congo Ebola Outbreak Claims 80 Lives; WHO Declares Emergency
At least 80 people have died in Congo’s new Bundibugyo Ebola outbreak, prompting the WHO to declare a public health emergency amid rapid regional…
Health Officials Respond to New Ebola Outbreak in Africa
A recent Ebola outbreak in Africa has caused dozens of deaths as health officials work to contain the virus, while a U.S. doctor who…
Deadly Ebola Strain Raises Alarms Amid Trump-Xi Summit
As President Trump concludes his summit with China’s Xi Jinping, a dangerous Ebola outbreak in central Africa is intensifying international health concerns
Ebola Survivor Warns of Risks to Healthcare Workers in Congo Outbreak
Dr. Craig Spencer, an Ebola survivor, expresses concern for healthcare workers amid a new outbreak in Congo with limited treatments available
Acting Head of FDA Drug Review Center Steps Down Amid Agency Turmoil
Dr. Tracy Beth Høeg departs as acting director of the FDA’s drug review center days after the commissioner’s resignation amid internal agency disputes
FDA Rejects Promising Melanoma Drug Amid Leadership Turmoil
The FDA denied accelerated approval for a melanoma treatment that helped some patients, highlighting concerns over trial design and agency leadership under outgoing commissioner…
NIH-backed tool improves pediatric amblyopia care access
A new NIH-supported online tool assists eye care providers in diagnosing and treating amblyopia, helping address specialist shortages across the U.S